Skip to main content
Tech.euFundingExplorerBeta

Audicin

Audicin develops an audio treatments designed for nervous system regulation

Audicin has raised €2.2M across 2 funding rounds from 3 investors, most recently a round in Apr 2026. Based in Helsinki, Finland; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€2.2M
€2,157,225
Funding rounds
2
Investors
3
distinct backers
Active since
2024-06
latest 2026-04

Funding by year

EUR raised per year · 2026 YTD
Audicin — funding by year — interactive chart.
Data table
Audicin — funding by year
2024€520k
2026€1.6M

Signals

High confidence
Raise-next likelihood33
base rate 30% for Other
  • ▼ In typical raise window
  • ▲ Up-round momentum
Exit likelihood11
base rate 11% (2+ rounds)
  • ▼ Young (<3y)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds

Related news

Similar companies

same sector or country

Global coverage: FundingData